{
    "Trade/Device Name(s)": [
        "AUTO-CHEK Blood Glucose Monitoring System",
        "AUTO-CHEK Blood Glucose Meter",
        "AUTO-CHEK Blood Glucose Test Strips",
        "AUTO-CHEK Control Solutions"
    ],
    "Submitter Information": "i-SENS, Inc.",
    "510(k) Number": "k121654",
    "Predicate Device Reference 510(k) Number(s)": [
        "k103396"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "August 1, 2012",
    "Summary Letter Received Date": "August 6, 2012",
    "Submission Date": "May 25, 2012",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Quality control material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AUTO-CHEK Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric method",
        "Glucose oxidase"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Meter",
        "Test Strip",
        "Control Solution",
        "Lancing Device",
        "Lancet"
    ],
    "Document Summary": "FDA 510(k) summary for AUTO-CHEK Blood Glucose Monitoring System using amperometric glucose oxidase technology for self-monitoring of blood glucose",
    "Indications for Use Summary": "Quantitative measurement of glucose in fresh capillary whole blood from fingertips and alternative sites; intended for self-testing by people with diabetes at home to monitor diabetes control, not for neonatal use or diagnosis/screening of diabetes",
    "fda_folder": "Clinical Chemistry"
}